The Current Ratio of Aeglea Bio Therapeutics Inc (AGLE) is 4.24.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
Date | Value |
---|---|
2022-12-31 | 4.24 |
2021-12-31 | 4.92 |
2020-12-31 | 9.13 |
2019-12-31 | 4.05 |
2018-12-31 | 7.52 |
2017-12-31 | 9.82 |
2016-12-31 | 16.60 |
2015-12-31 | 15.32 |
2014-12-31 | 2.45 |
2013-12-31 | 3.29 |